🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aiko Nagayama

Keio University

ORCID: 0000-0002-7453-8132

Also affiliated with Keio University Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment”.

MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment

npj Breast Cancer(2025)10.1038/s41523-025-00751-w

N/A

0.292DataRank · unranked

6 citations

Atrayee Bhattacharya, Hiroki Ozawa, Naoki Haratake, Keisuke Shigeta, Atsushi Fushimi +16 more

Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

Nature Communications(2024)10.1038/s41467-024-45693-2

N/A

0DataRank · unranked

19 citations

Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang +19 more

Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

Nature Communications(2024)10.1038/s41467-024-48241-0

N/A

0DataRank · unranked

0 citations

Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang +19 more